These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8371149)

  • 61. Effects of hyperglycemia on glucose transporters of the muscle: use of the renal glucose reabsorption inhibitor phlorizin to control glycemia.
    Dimitrakoudis D; Vranic M; Klip A
    J Am Soc Nephrol; 1992 Nov; 3(5):1078-91. PubMed ID: 1482748
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Non-insulin and non-exercise related increase of glucose utilization in rats and mice.
    Ohira Y; Ishine S; Tabata I; Kurata H; Wakatsuki T; Sugawara S; Yasui W; Tanaka H; Kuroda Y
    Jpn J Physiol; 1994; 44(4):391-402. PubMed ID: 7869601
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rehmannia glutinosa (Gaertn.) DC. polysaccharide ameliorates hyperglycemia, hyperlipemia and vascular inflammation in streptozotocin-induced diabetic mice.
    Zhou J; Xu G; Yan J; Li K; Bai Z; Cheng W; Huang K
    J Ethnopharmacol; 2015 Apr; 164():229-38. PubMed ID: 25698243
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Metabolic Effects of Metformin in Humans.
    Adeva-Andany MM; Rañal-Muíño E; Fernández-Fernández C; Pazos-García C; Vila-Altesor M
    Curr Diabetes Rev; 2019; 15(4):328-339. PubMed ID: 30306875
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential hypoglycemic effect of 2,5-anhydro-D-mannitol, a putative gluconeogenesis inhibitor, in genetically diabetic (db/db) and streptozotocin-induced diabetic mice.
    Kodama H; Fujita M; Yamaguchi I
    Jpn J Pharmacol; 1994 Nov; 66(3):331-6. PubMed ID: 7869620
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Metformin supports the antidiabetic effect of a sodium glucose cotransporter 2 inhibitor by suppressing endogenous glucose production in diabetic mice.
    Neschen S; Scheerer M; Seelig A; Huypens P; Schultheiss J; Wu M; Wurst W; Rathkolb B; Suhre K; Wolf E; Beckers J; Hrabé de Angelis M
    Diabetes; 2015 Jan; 64(1):284-90. PubMed ID: 25071027
    [TBL] [Abstract][Full Text] [Related]  

  • 67. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
    Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
    J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
    Singh V; Grötzinger C; Nowak KW; Zacharias S; Göncz E; Pless G; Sauer IM; Eichhorn I; Pfeiffer-Guglielmi B; Hamprecht B; Wiedenmann B; Plöckinger U; Strowski MZ
    Endocrinology; 2007 Aug; 148(8):3887-99. PubMed ID: 17525126
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Xiao Ke Qing improves glycometabolism and ameliorates insulin resistance by regulating the PI3K/Akt pathway in KKAy mice.
    Li X; Li X; Wang G; Xu Y; Wang Y; Hao R; Ma X
    Front Med; 2018 Dec; 12(6):688-696. PubMed ID: 30421394
    [TBL] [Abstract][Full Text] [Related]  

  • 70. GABA dramatically improves glucose tolerance in streptozotocin-induced diabetic rats fed with high-fat diet.
    Sohrabipour S; Sharifi MR; Talebi A; Sharifi M; Soltani N
    Eur J Pharmacol; 2018 May; 826():75-84. PubMed ID: 29391158
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diurnal rhythms of glycogen metabolism in the liver and skeletal muscle in gold thioglucose induced-obese mice with developing insulin resistance.
    Chen C; Williams PF; Cooney GJ; Caterson ID
    Int J Obes Relat Metab Disord; 1992 Nov; 16(11):913-21. PubMed ID: 1337347
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Leptin therapy reverses hyperglycemia in mice with streptozotocin-induced diabetes, independent of hepatic leptin signaling.
    Denroche HC; Levi J; Wideman RD; Sequeira RM; Huynh FK; Covey SD; Kieffer TJ
    Diabetes; 2011 May; 60(5):1414-23. PubMed ID: 21464443
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nuclear magnetic resonance studies of hepatic glucose metabolism in humans.
    Roden M; Petersen KF; Shulman GI
    Recent Prog Horm Res; 2001; 56():219-37. PubMed ID: 11237214
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of dietary palmitoleic acid on vascular function in aorta of diabetic mice.
    Takenouchi Y; Seki Y; Shiba S; Ohtake K; Nobe K; Kasono K
    BMC Endocr Disord; 2022 Apr; 22(1):103. PubMed ID: 35436932
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Appropriate Insulin Level in Selecting Fortified Diet-Fed, Streptozotocin-Treated Rat Model of Type 2 Diabetes for Anti-Diabetic Studies.
    Okoduwa SI; Umar IA; James DB; Inuwa HM
    PLoS One; 2017; 12(1):e0170971. PubMed ID: 28129400
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Liver and muscle insulin sensitivity, glycogen concentration and glycogen synthase activity in a rat model of non-insulin-dependent diabetes.
    Kruszynska YT; Home PD
    Diabetologia; 1988 May; 31(5):304-9. PubMed ID: 3135217
    [TBL] [Abstract][Full Text] [Related]  

  • 77. DBM mice as a pharmacological model of maturity onset diabetes. Studies with metformin.
    Junien JL; Brohon J; Guillaume M; Sterne J
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):165-76. PubMed ID: 526068
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.
    Niu Y; Liu W; Tian C; Xie M; Gao L; Chen Z; Chen X; Li L
    Eur J Pharmacol; 2007 Oct; 572(2-3):213-9. PubMed ID: 17651728
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sodium-Glucose Cotransporter 2 Inhibitor and a Low Carbohydrate Diet Affect Gluconeogenesis and Glycogen Content Differently in the Kidney and the Liver of Non-Diabetic Mice.
    Atageldiyeva K; Fujita Y; Yanagimachi T; Mizumoto K; Takeda Y; Honjo J; Takiyama Y; Abiko A; Makino Y; Haneda M
    PLoS One; 2016; 11(6):e0157672. PubMed ID: 27327650
    [TBL] [Abstract][Full Text] [Related]  

  • 80. TGR5 agonist ameliorates insulin resistance in the skeletal muscles and improves glucose homeostasis in diabetic mice.
    Huang S; Ma S; Ning M; Yang W; Ye Y; Zhang L; Shen J; Leng Y
    Metabolism; 2019 Oct; 99():45-56. PubMed ID: 31295453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.